While the reduction in price target could suggest a slightly less optimistic outlook on Amgen's future stock performance, the maintenance of a Buy rating indicates continued confidence in the company's fundamentals. This mixed signal could lead to a neutral short-term impact on Amgen's stock price as investors weigh the lowered price target against the sustained positive rating.